Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FATE THERAPEUTICS INC Director's Dealing 2016

Nov 28, 2016

34091_dirs_2016-11-28_f0926c03-678a-4931-8087-efda6ebd6be9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FATE THERAPEUTICS INC (FATE)
CIK: 0001434316
Period of Report: 2016-11-23

Reporting Person: RASTETTER WILLIAM H (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-11-23 Common Stock P 375939 $2.66 Acquired 459272 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 118360 Indirect

Footnotes

F1: Represents shares acquired in a private placement pursuant to the Securities Purchase Agreement dated November 21, 2016 by and among the issuer and the purchasers named therein.

F2: These shares are owned of record by The Investment 2002 Trust, dated November 11, 2002 for which William H. Rastetter is the sole trustee and owner.

F3: These shares are owned of record by The Rastetter Family Trust, dated September 2, 2010 for which William H. Rastetter and Marisa Gard Rastetter serve as co-trustees.